FDA Inspection
Northwestern MedicineNorthwestern Medicine – FDA Inspection, Apr 2, 2025
Record Details
This FDA Inspection record concerns Northwestern Medicine, with an inspection on April 2, 2025, issued by the Chicago District Office, covering biologics.
View Company Profile
ID · 65d3ffc0-1ba8-4be5-a0d2-28dfb7b51296
Inspection Facts
- Inspection number
- 1265805
- FDA center
- Biologics
Other FDA inspections of Northwestern Medicine
5| Date | Classification | Office | Project area |
|---|---|---|---|
| February 26, 2020 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 31, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 7, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 4, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 22, 2010 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Northwestern Medicine
- FDA Inspection 1121895 - 2020-02-26
- FDA Inspection 1014180 - 2017-05-31
- FDA Inspection 918294 - 2015-03-07
- FDA Inspection 833833 - 2013-06-04
- FDA Inspection 703407 - 2010-12-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.